Merck Enters into Exclusive Global License Agreement with Hansoh …
19 hours ago · Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535. Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments associated with the development, regulatory approval and commercialization of the ...
Merck reaches weight-loss drug deal worth up to $2 billion with …
1 day ago · Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named HS-10535. It includes an upfront $112 million licensing rights payment for ...
Merck Enters into Exclusive Global License Agreement with Hansoh …
19 hours ago · Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535. ... This news release of Merck & Co., Inc., Rahway, N.J., USA ...
Merck signs up to $2 bln obesity drug deal with Chinese biotech Hansoh …
19 hours ago · Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity on Wednesday, becoming a late contender in the race to offer a ...
Merck Enters Into Exclusive Global License Agreement With Hansoh …
18 hours ago · (RTTNews) - Merck & Co., Inc. (MRK), Wednesday announced that the company has entered into an exclusive global license deal with China-based Hansoh Pharma to develop, manufacture and commercialize ...
Merck to develop weight loss pill from Chinese drugmaker in up …
18 hours ago · Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in milestone payments and royalties on sales, according to a news release.
Merck, Hansoh Pharma in Obesity Pill License Potentially Worth …
18 hours ago · Merck on Wednesday said it will make an upfront payment of $112 million to Hansoh in exchange for an exclusive global license to HS-10535, an investigational small-molecule GLP-1 receptor agonist.
Merck signs deal worth up to $2 billion with China's Hansoh for
Merck said it will pay $112 million upfront for an exclusive license to the drug known as HS-10535. Under the deal, Hansoh will be eligible to receive up to $1.9 billion in development and ...
Viking Crumbles After Merck Inks A $2.01 Billion Obesity Deal
17 hours ago · Hansoh is also eligible to receive up to $1.9 billion in milestone payments as well as royalties on sales. While Merck stock was minimally moved, up just 1.3% to 101, Viking Therapeutics stock ...
Merck moves into obesity with deal for Hansoh’s GLP-1 pill
19 hours ago · News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen as likely buyout targets.